Loading…
Adicet Bio, Inc. is projected to rise to $8.61 by 2027, a +1% move from its current price of $8.50. ACET is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $8.20 | $8.50 | $8.81 | -0.05% |
| May 30 | $8.07 | $8.49 | $8.93 | -0.10% |
| May 31 | $7.98 | $8.49 | $9.03 | -0.16% |
| Jun 1 | $7.89 | $8.48 | $9.11 | -0.21% |
| Jun 2 | $7.82 | $8.48 | $9.19 | -0.26% |
| Jun 3 | $7.76 | $8.47 | $9.25 | -0.31% |
| Jun 4 | $7.70 | $8.47 | $9.31 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.70 | $8.47 | $9.31 | -0.36% |
| Week 2 | $7.38 | $8.44 | $9.65 | -0.73% |
| Week 3 | $7.13 | $8.41 | $9.91 | -1.09% |
| Week 4 | $6.93 | $8.38 | $10.13 | -1.45% |
| Week 5 | $6.75 | $8.35 | $10.32 | -1.81% |
| Week 6 | $6.59 | $8.32 | $10.49 | -2.16% |
| Week 7 | $6.44 | $8.29 | $10.65 | -2.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Adicet Bio, Inc. is a clinical stage biotechnology company that discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. Its lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases.
The company also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen.
Adicet Bio, Inc. trades under the symbol ACET and operates in the healthcare sector. The current price is $8.30 per share with a market capitalization of $77.59M, and the stock is ranked 4386 by market cap. The forecast shows a path of rising averages and ROIs across the coming years, starting from 2026 onward.
A major floor 28.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.7% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 12.5% above — clearing it would confirm fresh momentum.
Key ACET support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACET market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.16 | Buy | $8.21 | Buy |
| MA 10 | $7.97 | Buy | $8.09 | Buy |
| MA 20 | $8.08 | Buy | $8.01 | Buy |
| MA 50 | $7.55 | Buy | $7.80 | Buy |
| MA 100 | $7.60 | Buy | $8.06 | Buy |
| MA 200 | $9.50 | Sell | $9.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.25 | Neutral |
| Stoch RSI (14) | 83.90 | Sell |
| CCI (20) | 82.01 | Neutral |
| Williams %R (14) | -3.85 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.58 | Sell |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 96.15 | Sell |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | 0.24 | Buy |
| Ultimate (7,14,28) | 64.21 | Neutral |
| Momentum (10) | 0.55 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 8.47 | Buy |
| ADX (14) | 12.47 | Neutral |
| ATR (14) | 0.26 | Info |
Technical sentiment is NEUTRAL. The RSI14 stands at 60, with the 50-day simple moving average at $7.50 and the 200-day simple moving average at $9.52. Key near-term support is at $6.35 and resistance at $8.67. The 30-day price range runs from $6.47 to $10.65, illustrating notable but contained volatility. Annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.11 | $8.50 | $10.46 | 0% | Neutral | |
| $6.62 | $8.61 | $11.98 | +1% | Neutral | |
| $6.09 | $8.22 | $11.96 | -3% | Neutral | |
| $6.26 | $8.72 | $13.15 | +3% | Neutral | |
| $7.02 | $10.05 | $15.60 | +18% | Neutral | |
| $8.23 | $12.09 | $19.25 | +42% | Bullish | |
| $9.54 | $14.36 | $23.40 | +69% | Bullish | |
| $8.92 | $13.74 | $22.87 | +62% | Bullish | |
| $8.73 | $13.74 | $23.31 | +62% | Bullish | |
| $9.66 | $15.52 | $26.80 | +83% | Bullish | |
| $13.22 | $23.43 | $43.55 | +176% | Bullish | |
| $16.70 | $35.31 | $73.01 | +315% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.11 | $8.50 | $10.01 | +0.00% |
| June 2026 | $6.96 | $8.23 | $10.00 | -3.22% |
| July 2026 | $6.78 | $8.11 | $10.03 | -1.46% |
| August 2026 | $6.83 | $8.24 | $10.33 | +1.62% |
| September 2026 | $6.59 | $8.01 | $10.15 | -2.75% |
| October 2026 | $6.26 | $7.65 | $9.80 | -4.46% |
| November 2026 | $6.34 | $7.80 | $10.07 | +1.89% |
| December 2026 | $6.50 | $8.04 | $10.46 | +3.08% |
Click any year to see its month-by-month ACET forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ACET price prediction for 2026 points to an average of $8.50 (low $6.11, high $10.46) — a potential gain of 0% on today's $8.50. Price action looks broadly range-bound.
In 2027, ACET is projected to trade between $6.62 and $11.98, averaging $8.61 — a potential gain of +1% from today's $8.50. That is up +1% on the projected 2026 average. A consolidation phase looks the most probable path here.
Adicet Bio, Inc.'s 2028 outlook centres on $8.22, within a $6.09 to $11.96 range. That is -5% versus the projected 2027 average. That marks a -3% change versus current levels. Price action looks broadly range-bound.
By 2029, ACET could reach as high as $13.15, with a base case around $8.72 and support toward $6.26 — roughly +3% from $8.50. A consolidation phase looks the most probable path here.
Expect ACET to range from $7.02 to $15.60 through 2030. The $10.05 average target implies a +18% move from current prices. That is up +15% on the projected 2029 average. Price action looks broadly range-bound.
The ACET price prediction for 2031 points to an average of $12.09 (low $8.23, high $19.25) — a potential gain of +42% on today's $8.50. Buyers look set to stay in control over this stretch.
In 2032, ACET is projected to trade between $9.54 and $23.40, averaging $14.36 — a potential gain of +69% from today's $8.50. That is up +19% on the projected 2031 average. Momentum favours further upside here.
Adicet Bio, Inc.'s 2033 outlook centres on $13.74, within a $8.92 to $22.87 range. That is -4% versus the projected 2032 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ACET could reach as high as $23.31, with a base case around $13.74 and support toward $8.73 — roughly +62% from $8.50. Momentum favours further upside here.
Expect ACET to range from $9.66 to $26.80 through 2035. The $15.52 average target implies a +83% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ACET price prediction for 2040 points to an average of $23.43 (low $13.22, high $43.55) — a potential gain of +176% on today's $8.50. Momentum favours further upside here.
In 2050, ACET is projected to trade between $16.70 and $73.01, averaging $35.31 — a potential gain of +315% from today's $8.50. That is up +51% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ACET today (≈ 117.647059 ACET) could be worth
$4,154.67
+$3,154.67 (+315%) by 2050 · US Dollar
Based on the average projected ACET price of $35.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACETwould be worth at today's price.
$1,000 invested in ACET on May 27, 2025 (≈ 89.285716 ACET) would be worth
$758.93
-$241.07 (-24.1%) today · 0.76× · US Dollar
Based on a ACET entry price of $11.2 vs. today's $8.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.76 | $1,095.36 | +9.5% |
| 1 month ago | $7.93 | $1,071.88 | +7.2% |
| 3 months ago | $7.32 | $1,161.2 | +16.1% |
| 6 months ago | $10.37 | $819.83 | -18.0% |
| 1 year ago | $11.2 | $758.93 | -24.1% |
| All time (5.0y) ago | $198.24 | $42.88 | -95.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACET forecast.
Our base-case forecast reaches $17.00 around 2040.
Implied market cap at $17.00: $158.92M
The multi-year forecast outlines a progression from stability to stronger upside. In 2026 the avg price is $8.30 with a 0% ROI, signaling a neutral near-term stance. By 2030 the avg is $9.33 with a 12.5% ROI, and the path continues higher into later years.
In 2031 the avg rises to $11.35 with a 36.7% ROI, and by 2032 the avg is $13.36 with a 61% ROI. The trajectory remains bullish in 2033 ($12.72 avg, 53.3% ROI) and 2034 ($12.79 avg, 54.1% ROI), and strengthens further in 2035 ($14.26 avg, 71.9% ROI). In 2040 the avg is $21.48 with a 158.8% ROI, and by 2050 the avg reaches $31.42 with a 278.6% ROI.
These figures represent estimates of future price and return, not guarantees, and reflect varying levels of upside potential and risk over time.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $6.43, an avg of $9.33, and a max of $14.69 with a projected ROI of 12.5%.
The near term (2026) shows an avg price of $8.30 with a 0% ROI and NEUTRAL sentiment, while later years indicate potential upside (2031–2050) with higher avg prices and ROIs. These are estimates and not guarantees.
Yes. The 2050 forecast lists a max of $66.52 with an avg of $31.42 and a ROI of 278.6%, indicating substantial upside under the forecast.
Sentiment is NEUTRAL with RSI14 at 60. The SMA50 is $7.50 and the SMA200 is $9.52. Support is at $6.35 and resistance at $8.67, with a 30-day range of $6.47 to $10.65 and annualized volatility of 70%.
Current price is $8.30 and market cap is $77.59M, with a rank of 4386.
Adicet Bio, Inc. Community Discussion
0Share your Adicet Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.